We completely stay away from biotechs...just too many variables. I am sure there are some very big potential plays out there, but we just wont touch em.
When we invested in GENE, the DNA wave was breaking, they had key IP and they became a licensing machine. Mgmt's ridiculous salaries and their focus on a breast cancer test kit changed our love for the company.
The author of How To Find Big Stocks and publisher of the How To Find Big Stocks Newsletter
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.